OVERVIEW NYC's affluent are abandoning traditional healthcare for concierge medicine, continuous biometric monitoring, and personalized longevity protocols. The market has shifted decisively from treating illness to optimizing lifespan—driven by tech founders, wealth managers, and executives who view health as competitive advantage. Expect premium clinics, genetic testing, and AI-powered wellness platforms to become increasingly normalized among your peer group. KEY SIGNALS Concierge medical practices report 40% growth in NYC memberships (2023-2024). Wearable adoption among HNW individuals exceeds 70%. Direct-to-consumer genetic and metabolic testing revenue surged 35% YoY. Venture capital flowing to longevity tech has exceeded $8B annually. Corporate wellness budgets are decoupling from insurance—companies now fund employee optimization independently. WHAT TO WATCH Monitor emerging longevity clinics opening in Manhattan—these are becoming social hubs and deal-making venues for your network. Track regulatory shifts around telehealth, biomarker testing, and peptide therapies as they reshape what's accessible. Consider personal health data as new currency: employers and platforms will increasingly monetize and compete on biometric insights.
This is a members-only intelligence brief from Yesodi. Join to read the full analysis, discuss with community members, and access all briefs.
Join Yesodi →